Article
MeCP2 as an Activator of Gene Expression.
Trends in neurosciences - 1 Feb 2018
Horvath Patricia M, Monteggia Lisa M
Abstract excerpt
Rett syndrome is a neurodevelopmental disorder that primarily affects females and is caused by mutations in the methyl-CpG-binding-protein 2 (MECP2) gene. Initially, MeCP2 had been shown to be a repressor of gene transcription. In their 2008 paper, Chahrour and colleagues (DOI: 10.1126/science.1153252) reported that MeCP2 could also function as a transcriptional activator.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
